Simon Fletcher

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Orphanet journal of rare diseases

Haemophilia : the official journal of the World Federation of Hemophilia

Research and practice in thrombosis and haemostasis

Health expectations : an international journal of public participation in health care and health policy

Oxford University Hospitals NHS Foundation Trust

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oxford University Hospitals NHS Foundation Trust Oct 28 2012

United Kingdom

Lead Research Nurse :: Haemophilia and Thrombosis

Publications

Simon Fletcher, Kathryn Jenner, Michael Holland, Kate Khair
Barriers to gene therapy, understanding the concerns people with haemophilia have: an exigency sub-study. Orphanet journal of rare diseases 19 (1) (2024)
Simon Fletcher, Kathryn Jenner, Michael Holland, Kate Khair
Barriers to gene therapy, understanding the concerns people with haemophilia have: an exigency sub-study. Orphanet journal of rare diseases 19 (1) (2024)
Simon Fletcher, Kathryn Jenner, Michael Holland, Kate Khair
Barriers to gene therapy, understanding the concerns people with haemophilia have: an exigency sub-study. Orphanet journal of rare diseases 19 (1) (2024)
Simon Fletcher, Kathryn Jenner, Michael Holland, Kate Khair
Barriers to gene therapy, understanding the concerns people with haemophilia have: an exigency sub-study. Orphanet journal of rare diseases 19 (1) (2024)
Caroline Wall, Hua Xiang, Ben Palmer, Elizabeth A Chalmers, Pratima Chowdary, Peter W Collins, Simon Fletcher, Georgina W Hall, Daniel P Hart, Mary Mathias, Paul Sartain, Susan Shapiro, David Stephensen, Kate Talks, Charles R M Hay, null null
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO). Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Simon Fletcher, Kathryn Jenner, Michael Holland, Kate Khair
Expectation and loss when gene therapy for haemophilia is not an option: An exigency sub-study. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Simon Fletcher, Kathryn Jenner, Luke Pembroke, Michael Holland, Kate Khair
The experiences of people with haemophilia and their families of gene therapy in a clinical trial setting: regaining control, the Exigency study. Orphanet journal of rare diseases 17 (1) (2022)
Simon Fletcher, Kathryn Jenner, Michael Holland, Kate Khair
The lived experience of a novel disruptive therapy in a group of men and boys with haemophilia A with inhibitors: Emi & Me. Health expectations : an international journal of public participation in health care and health policy (2021)
Simon Fletcher, Kathryn Jenner, Michael Holland, Steve Chaplin, Kate Khair
An exploration of why men with severe haemophilia might not want gene therapy: The exigency study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Kate Khair, Michael Holland, Sandra Dodgson, Paul Mclaughlin, Simon Fletcher, Deborah Christie
Fitness enhances psychosocial well-being and self-confidence in young men with hemophilia: Results from Project GYM. Research and practice in thrombosis and haemostasis 5 (8) (2021)
Kate Khair, Lisa Steadman, Steve Chaplin, Michael Holland, Kathryn Jenner, Simon Fletcher
Parental perspectives on gene therapy for children with haemophilia: The Exigency study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)

Simon Fletcher.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Simon Fletcher